Daegu, South Korea

Eun Joo Cho


 

Average Co-Inventor Count = 11.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Gyeonggi-do, KR (2016)
  • Incheon, KR (2017)
  • Daegu, KR (2019)

Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Eun Joo Cho: Innovator in Cosmetic and Pharmaceutical Patents

Introduction

Eun Joo Cho is a prominent inventor based in Daegu, South Korea. She has made significant contributions to the fields of cosmetics and pharmaceuticals, holding a total of 3 patents. Her innovative work focuses on developing effective solutions for skin care and cancer treatment.

Latest Patents

Eun Joo Cho's latest patents include a stable peptide-conjugated ascorbic acid derivative and an antibody-linker-drug conjugate. The stable peptide-conjugated ascorbic acid derivative is designed to provide skin whitening effects by inhibiting melanin production while also reducing skin wrinkles through collagen activation. This invention is particularly valuable in cosmetic compositions. The antibody-linker-drug conjugate involves a unique preparation method that allows for the direct binding of a cytotoxic drug to an antibody, enhancing the efficacy of anticancer treatments.

Career Highlights

Eun Joo Cho is currently associated with Celltrion Inc., a leading biopharmaceutical company. Her work at Celltrion has positioned her as a key player in the development of innovative therapeutic solutions.

Collaborations

Eun Joo Cho collaborates with notable colleagues such as Young Jun Park and Seung Suh Hong. Their combined expertise contributes to the advancement of their projects and the overall success of their innovations.

Conclusion

Eun Joo Cho's contributions to the fields of cosmetics and pharmaceuticals highlight her role as a leading inventor. Her innovative patents reflect her commitment to improving skin care and cancer treatment solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…